SK bioscience Co.,Ltd. (KRX:302440)
South Korea · Delayed Price · Currency is KRW 35,000
+650 (1.89%)
Jul 27, 2026, 12:50 PM KST
SK bioscience Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, SK bioscience stock has a consensus rating of "Sell" and an average price target of ₩33,250. The average 1-year stock price forecast is 5.00% lower than the current stock price, while the lowest is ₩25,000 (-28.57%) and the highest is ₩46,000 (+31.43%).
Price Target: ₩33,250 (-5.00%)
Analyst Consensus: Sell
Price Target
ChartAnalyst Ratings
The average analyst rating for SK bioscience stock is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.
Recommendation Trends
| Rating | Nov '25 | Jan '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 3 | 2 | 2 | 1 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Total | 6 | 6 | 6 | 5 | 5 | 4 |
Financial Forecast
Revenue This Year
720.68B
from 651.37B
Increased by 10.64%
Revenue Next Year
768.52B
from 720.68B
Increased by 6.64%
EPS This Year
-1.15K
from -733.00
EPS Next Year
-941.43
from -1.15K
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is KRW.